Whipple's disease differential diagnosis: Difference between revisions
Line 29: | Line 29: | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause/Pathogenesis | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Cause/Pathogenesis | ||
! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" |Gold standard diagnosis | ||
! rowspan="3" |Treatment | |||
|- | |- | ||
! colspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Diarrhea | ! colspan="2" align="center" style="background:#7d7d7d; color: #FFFFFF;" |Diarrhea | ||
Line 73: | Line 74: | ||
| | | | ||
* [[small intestine]] [[biopsy]] for [[Tropheryma whipplei|Tropheryma whipplei]] testing | * [[small intestine]] [[biopsy]] for [[Tropheryma whipplei|Tropheryma whipplei]] testing | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ! align="center" style="background:#DCDCDC;" |[[Celiac disease]] | ||
Line 110: | Line 112: | ||
* [[IgA]] endomysial antibody | * [[IgA]] endomysial antibody | ||
* [[IgA]] tissue transglutaminase antibody | * [[IgA]] tissue transglutaminase antibody | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Grain allergy | ! align="center" style="background:#DCDCDC;" |Grain allergy | ||
Line 135: | Line 137: | ||
| | | | ||
* Measurement of grain-specific [[IgE|immunoglobulin E (IgE)]] | * Measurement of grain-specific [[IgE|immunoglobulin E (IgE)]] | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ! align="center" style="background:#DCDCDC;" |[[Cystic fibrosis]] | ||
Line 164: | Line 167: | ||
| | | | ||
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | * Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ||
Line 192: | Line 196: | ||
| | | | ||
* [[Hydrogen Breath Test|Lactose breath hydrogen test]] | * [[Hydrogen Breath Test|Lactose breath hydrogen test]] | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]] | ! align="center" style="background:#DCDCDC;" |[[Crohns disease|Crohns disease]] | ||
Line 223: | Line 228: | ||
| | | | ||
* [[Colonoscopy]] with [[biopsy]] | * [[Colonoscopy]] with [[biopsy]] | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]] | ! align="center" style="background:#DCDCDC;" |[[Laxative abuse|Laxative overuse]] | ||
Line 250: | Line 256: | ||
** [[Laxatives|Diphenolic laxatives]] (eg, [[bisacodyl]]) | ** [[Laxatives|Diphenolic laxatives]] (eg, [[bisacodyl]]) | ||
** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]] | ** [[Polyethylene glycol|Polyethylene glyco]]<nowiki/>l-containing [[laxatives]] | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ! align="center" style="background:#DCDCDC;" |[[Hyperthyroidism]] | ||
Line 281: | Line 288: | ||
| | | | ||
* [[TSH]] | * [[TSH]] | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ! align="center" style="background:#DCDCDC;" |[[Irritable bowel syndrome]] | ||
Line 307: | Line 315: | ||
** ROME III criteria | ** ROME III criteria | ||
** [[Pharmacological|Pharmacologic]] studies based criteria | ** [[Pharmacological|Pharmacologic]] studies based criteria | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ! align="center" style="background:#DCDCDC;" |[[VIPoma]] | ||
Line 340: | Line 349: | ||
* Elevated [[VIP]] levels | * Elevated [[VIP]] levels | ||
* Followed by imaging | * Followed by imaging | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]]) | ! align="center" style="background:#DCDCDC;" |[[Gastrinoma]] ([[Zollinger-Ellison syndrome|Zollinger-Ellison syndrome]]) | ||
Line 363: | Line 373: | ||
| | | | ||
* Elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL | * Elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ! align="center" style="background:#DCDCDC;" |[[Lactose intolerance]] | ||
Line 392: | Line 403: | ||
| | | | ||
* [[Lactase]] activity assay | * [[Lactase]] activity assay | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ! align="center" style="background:#DCDCDC;" |Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | ||
Line 418: | Line 430: | ||
| | | | ||
* [[Oral]] food challenge (OFC) | * [[Oral]] food challenge (OFC) | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ! align="center" style="background:#DCDCDC;" |[[Eosinophilic gastroenteritis]] | ||
Line 444: | Line 457: | ||
| | | | ||
* [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | * [[Eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]] | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption | ! align="center" style="background:#DCDCDC;" |Primary bile acid malabsorption | ||
Line 467: | Line 481: | ||
* Total and specific [[bile acid]]<nowiki/>s from stool | * Total and specific [[bile acid]]<nowiki/>s from stool | ||
* [[Gamma emitter selenium-75-homocholic acid taurine]] (SeHCAT) | * [[Gamma emitter selenium-75-homocholic acid taurine]] (SeHCAT) | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ! align="center" style="background:#DCDCDC;" |[[Abetalipoproteinemia]] | ||
Line 496: | Line 511: | ||
| | | | ||
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level | * Clinical findings and low [[triglyceride]] and [[cholesterol]] level | ||
| | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ! align="center" style="background:#DCDCDC;" |[[Microscopic colitis]] | ||
Line 529: | Line 545: | ||
** [[Collagenous colitis]] is characterized by a colonic subepithelial [[collagen]] band >10 micrometers in diameter | ** [[Collagenous colitis]] is characterized by a colonic subepithelial [[collagen]] band >10 micrometers in diameter | ||
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells | ||
| | |||
|} | |} | ||
Revision as of 15:27, 30 October 2017
Whipple's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Whipple's disease differential diagnosis On the Web |
American Roentgen Ray Society Images of Whipple's disease differential diagnosis |
Risk calculators and risk factors for Whipple's disease differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2]
Overview
Whipple's disease must be differentiated from other diseases that cause malabsorption, chronic diarrhea, multi system involvement, such as Celiac disease, systemic infections, and inflamatory bowel disease.
Differentiating Whipple's disease from other Diseases
Whipple's disease must be differentiated from other diseases that cause malabsorption, chronic diarrhea, joins involvement, and neurologic symptoms.
- Malabsorption with small intestine involvement (celiac disease, sarcoidosis, and lymphoma)
- Infections such as tuberculosis, endemic fungi (eg, Histoplasma spp), Rhodococcus and HIV infection
- Inflammatory bowel diseases
- Connective tissue diseases
- Neurologic disease
- Addison's disease
The following diseases have presentations similar to that of Whipple's disease.
The table below summarizes the diseases that cause malabsorption, diarrhea and abdominal pain.[1][2][3][4][5][6][7][8]
Abbreviations: WBC: White blood cells; Plt: Platelets; Hgb: Hemoglobin ; IgE: Immunoglobulin E ; IgA: Immunoglobulin A ;
Cause | Peak age of onset | History | Physical exam | Lab findings | Additional finding | Cause/Pathogenesis | Gold standard diagnosis | Treatment | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Diarrhea | Fever | Weight loss | Abdominal pain | Arthralgia | ||||||||||||
Watery | Fatty | WBC | Hgb | Plt | Other lab findings | |||||||||||
Whipple's disease | 50th | +/- | + | + | + | + | + | ↓ | ↓ | ↓ |
|
|||||
Celiac disease | Childhood
Adult |
+/- | +/- | - | + | + | + | - | ↓ | - |
|
|
|
|||
Grain allergy | Childhood | + | - | - | + | + | - |
|
|
|
||||||
Cystic fibrosis | Infancy and childhood | - | + | + | + |
|
|
|
||||||||
Lactose intolerance | Adult | + | - | - | + |
|
||||||||||
Crohns disease | Young adults
(20th) |
+ | - | + | + |
|
|
|
|
|
||||||
Laxative overuse | After childhood | + | - | +/- | +/- |
|
|
- |
|
|
||||||
Hyperthyroidism | Any age | + | - | + | +/- |
|
||||||||||
Irritable bowel syndrome | Between 30 and 50 | + | - | - | + |
|
- |
|
|
|||||||
VIPoma | Between 30 and 50 | + | - | + | +/- |
|
|
|
|
|||||||
Gastrinoma (Zollinger-Ellison syndrome) | Between the ages of 20 and 50 | + | - | + | + |
|
|
|
||||||||
Lactose intolerance | Any age | - | + | + | +/- |
|
|
|
|
|||||||
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) | Infancy | + | - | +/- | + | Stool examination:
|
|
|
|
|||||||
Eosinophilic gastroenteritis | 30th | + | - | +/- | + |
|
|
|
||||||||
Primary bile acid malabsorption | Childhood Adolescents | + | +/- | + | +/- | - |
|
|
|
|
||||||
Abetalipoproteinemia | Infancy | - | + | + | + |
|
|
|
|
|
||||||
Microscopic colitis | 60th | + | - | + | + |
|
|
|
|
References
- ↑ Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
- ↑ Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
- ↑ BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.
- ↑ SCOBIE BA, MCGILL DB, PRIESTLEY JT, ROVELSTAD RA (1964). "EXCLUDED GASTRIC ANTRUM SIMULATING THE ZOLLINGER-ELLISON SYNDROME". Gastroenterology. 47: 184–7. PMID 14201408.
- ↑ Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
- ↑ Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
- ↑ Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
- ↑ RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.